Part D Reporting Requirements
Guidance for Part D plan sponsors containing information summarizing Part D plan sponsor responsibilities regarding fraud, waste, and abuse in the Prescription Drug Program and provides an overview of CMS reporting requirements.
Issued by: Centers for Medicare & Medicaid Services (CMS)
Issue Date: February 06, 2020
This section contains information related to the Part D reporting requirements. Each Part D plan sponsor must have an effective procedure to develop, compile, evaluate, and report information to CMS in the time and manner that CMS requires. The Part D reporting requirements and technical specifications describe the required level of reporting, timeframes, deadlines, and specific data elements for each reporting section.
Final Part D reporting requirements are posted in the downloads section of this page.
HHS is committed to making its websites and documents accessible to the widest possible audience, including individuals with disabilities. We are in the process of retroactively making some documents accessible. If you need assistance accessing an accessible version of this document, please reach out to the guidance@hhs.gov.
DISCLAIMER: The contents of this database lack the force and effect of law, except as authorized by law (including Medicare Advantage Rate Announcements and Advance Notices) or as specifically incorporated into a contract. The Department may not cite, use, or rely on any guidance that is not posted on the guidance repository, except to establish historical facts.